Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 1,324 GBp
Change Today +29.00 / 2.24%
Volume 4.4M
GSK On Other Exchanges
Symbol
Exchange
OTC US
London
Mexico
Frankfurt
As of 9:48 AM 09/2/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Christophe Weber

AgeTotal Calculated CompensationThis person is connected to 16 board members in 1 different organizations across 2 different industries.

See Board Relationships
49¥508,000,000

Background*

Mr. Christophe Weber has been the President and Chief Executive Officer of Takeda Pharmaceutical Company Limited since June 27, 2014 and April 1, 2015 respectively and served as its Chief Operating Officer from April 1, 2014 to April 1, 2015. Mr. Weber served as the President of Vaccines at GlaxoSmithKline plc since April 2012. He served as the President of Biologicals at GlaxoSmithKline plc since April 2012. He served as the Head of Asian Business of GlaxoSmithKline ...

Read Full Background

Corporate Headquarters*

980 Great West Road
Brentford, Middlesex TW8 9GS

United Kingdom

Phone: 44 20 8047 5000
Fax: --

Board Members Memberships*

2014-Present
Chief Executive Officer, President and Representative Director

Education*

There is no Education data available.

Other Affiliations*

Annual Compensation*

Salary¥174,000,000
Bonus¥56,000,000
Total Annual Compensation¥230,000,000

Stock Options*

Long Term Incentive Plan¥186,000,000
All Other Compensation¥92,000,000

Total Compensation*

Total Annual Cash Compensation¥322,000,000
Total Short Term Compensation¥230,000,000
Other Long Term Compensation¥92,000,000
Total Calculated Compensation¥508,000,000
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GSK:LN 1,324.00 GBp +29.00

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
George A. Scangos Ph.D.Chief Executive Officer and Director
Biogen Inc.
$1.4M
Vincent A. Forlenza Chairman, Chief Executive Officer, President and Chairman of Executive Committee
Becton, Dickinson and Company
$985.0K
Miles D. White Chairman, Chief Executive Officer and Chairman of Executive Committee
Abbott Laboratories
$2.0M
Robert L. Parkinson Jr.Chairman, Chief Executive Officer and President
Baxter International Inc.
$1.5M
Karl-Ludwig Kley Chairman of Executive Board and Chief Executive Officer
Merck KGaA
€6.6M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GLAXOSMITHKLINE PLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.